Psychedelics

A bipartisan proposal by Sens. Cory Booker (D-NJ) and Rand Paul (R-KY) would improve research opportunities for psychedelics by rescheduling any drugs given a “breakthrough therapy” designation by the FDA.

A nearly 70% majority of Oregon counties have voted to ban psilocybin access in response to the state’s 2020 medical psilocybin legalization vote.

Colorado voters passed the legalization of psychedelic mushrooms on Tuesday; the move will let people aged 21 or older grow and share psychedelic mushrooms and will establish state-regulated “healing centers” where people can make appointments to consume psilocybin in a controlled environment.

The result of the ballot initiative to decriminalize and regulate psychedelics in Colorado is still too close to call the day after Tuesday’s elections.

Six municipalities in Oregon will vote in the midterm elections on whether to ban the use and production of psychedelics within their jurisdictions.

Voters in Colorado will vote next month on the legalization of psilocybin and psilocin for therapeutic purposes.

Multiple Oregon municipalities are planning to put psilocybin therapy bans on November election ballots after state voters opted to legalize the treatment in 2020.

A federal survey found that U.S. young adults aged 19 to 30 used more cannabis and hallucinogens in 2021 than in any previous year.

The Zide Chruch of Entheogenic Plants, a church in Oakland, California that uses cannabis and psychedelics as communion, has filed a lawsuit against the city and its police department over a 2020 raid of their site.

In a recent podcast interview, Green Bay Packers quarterback Aaron Rodgers credited the psychedelic ayahuasca for what he called “the best season” of his career.

Filament Health has begun its Phase 1 study investigating naturally-derived psilocin and psilocybin, the first such study ever approved by the FDA.

New York Rep. Alexandria Ocasio-Cortez introduced an amendment this week to the 2023 National Defense Authorization Act that would require the Department of Defense to study the therapeutic potential of psychedelics for veterans.

Kim Stuck is the founder of Allay Consulting, a hemp, cannabis, and psychedelics compliance consultant firm.

Matthew X. Lowe, Ph.D., is the Research Director for Realm of Caring — a cannabis non-profit focused on increasing access to cannabis medicine — and Research Director for Unlimited Sciences, a psychedelics research non-profit.

Police arrested activists outside of the headquarters of the DEA as they protested the agency’s refusal to let terminally ill patients access experimental drugs like psilocybin and MDMA.

Utah lawmakers overwhelmingly approved a bill to establish a task force for researching the psychotherapeutic potential of psychedelics.

The Oregon Senate Human Services, Mental Health, and Recovery Committee unanimously approved a measure to regulate the state’s emerging psilocybin program.

The Ninth Circuit U.S. Court of Appeals dismissed a lawsuit against the DEA this week filed by cancer patients who are seeking to use psilocybin to treat end-of-life depression and anxiety.

Washington State Democratic Senators Jesse Salomon and Liz Lovelett have introduced a bill to legalize the assisted adult use of psilocybin.

A set of GOP companion bills in the House and Senate seeking to curb illegal fentanyl sales would also streamline the research of cannabis, psychedelics, and other Schedule I substances.

A new study found that psilocybin may be able to reverse alcohol brain damage, reduce alcohol-addictive behavior, and reduce relapse rates.

Detroit voters decided to decriminalize psilocybin and the therapeutic use of other entheogenic plants during last week’s election.